Quarry LP’s Avita Medical RCEL Stock Holding History

Quarry LP’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$5	–	2527
2025 Q3	$5	Sell	1 -5,852	-100%	-$30.5K	﹤0.01%	2137
2025 Q2	$31K	Buy	+5,853	New	+$42.6K	0.01%	1035

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Quarry LP's RCEL Position: Q4 2025 in Review

Quarry LP sold out of Avita Medical (RCEL) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

Quarry LP first reported a position in RCEL in Q2 2025 and held it in 2 quarters. The position peaked at $31K in Q2 2025. 67 funds tracked by Wall St. Rank hold RCEL as of Q4 2025.

Quarry LP reported no remaining Avita Medical position as of Q4 2025 after selling out during the quarter.
Quarry LP sold 1 Avita Medical share in Q4 2025, an estimated $5.
Quarry LP first reported a position in Avita Medical in Q2 2025 and held it in 2 quarters.
Quarry LP's Avita Medical position peaked at $31K in Q2 2025.
67 funds tracked by Wall St. Rank held Avita Medical as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.